Investor profile for Sofinnova Partners: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

Sofinnova Partners stages, portfolio and investment profile

European life-sciences venture capital firm investing from company creation through later-stage healthcare and sustainability opportunities.

Keep track of Sofinnova Partners

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$1M–$10M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: September 28, 2026 View methodology

Investment stages

Leads: Not recorded

Participates: Pre-Seed, Seed, Series A, Series B, Series B+, Series C, Growth

Sector focus

healthtech · biotech-life-sciences · climate-tech

Geography

Paris, London and Milan

Founded 1972

Fund size / AUM

More than €4B

A separate fund-size evidence record is not yet available.

Portfolio in our directory

None yet

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Rounds they invest

Pre-Seed Seed Series A Series B Series B+ Series C Growth

Last verified: 2026-09-28. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.